Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-26-000133

Options or other derivatives

  • Chief Executive Officer acquired 151,172 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kelderman Kim Chief Executive Officer 2026-08-17 Grant or award · Restricted Stock Units +57,590 57,590 D: show line 1 in the form
Kelderman Kim Chief Executive Officer 2026-08-17 Grant or award · Restricted Stock Units +93,582 93,582 D: show line 2 in the form
Loading xslF345X06/form4.xml…